# Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury

> **NCT07413562** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Cognitive Dysfunction

## Interventions

- **DEVICE:** Median nerve stimulation
- **DRUG:** Sham

## Key facts

- **NCT ID:** NCT07413562
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07413562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07413562, "Feasibility, Safety, and Preliminary Efficacy of Median Nerve Stimulation for Cognitive Dysfunction in Patients With Acute Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07413562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*